COVID-19 Helped People Understand the Loneliness Cancer Survivors Face

Video

Patients with cancer often experience loneliness, and the COVID-19 pandemic helped the general public better understand what that isolation felt like, an expert said.

The COVID-19 pandemic made the general public have a better understanding of what it is like for patients with cancer or other illnesses to feel isolated and lonely, explained Beth Blakey.

In a recent interview with CURE®, Blakey, who is the executive director of Cancer Hope Network, discussed the current “loneliness epidemic,” and how organizations and cancer centers can help curb these feelings for patients and their loved ones, especially as loneliness has been associated with poorer outcomes and negative health behaviors for patients with cancer.

In one study of adolescent and young adult cancer survivors, patients who reported feelings of loneliness were more likely to smoke and experience anxiety and depression. Additionally, childhood cancer survivors who reported loneliness were more likely to heavily consume alcohol, have suicidal ideation and new-onset moderate to life-threatening chronic conditions.

READ MORE: Support Groups Address Loneliness of a Cancer Diagnosis for Patients, Caregivers

Blakey said that these feelings of loneliness were common for patients with cancer who are undergoing treatments and are immunocompromised.

“It's something that people are now understanding and experiencing themselves,” she said in an interview with CURE. “So I think the pandemic really did kind of shine a light on that and help people to be able to empathize in a very different way than really ever before.”

Transcript

So, you know, it's interesting, when the pandemic happened, when we were talking to our cancer survivors who are volunteers, there were several conversations where they said, “People now more broadly understand what it feels like to be somebody experiencing cancer — that isolation, that loneliness that somebody's experiencing cancer, or really any critical illness, for that matter, how they feel.”

It's something that people are now understanding and experiencing themselves. So, I think the pandemic really did kind of shine a light on that and help people to be able to empathize in a very different way than really ever before.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE